Department of Cardiovascular Medicine, Chiba University Graduate School of Medicine, 1-8-1 Inohana, Chuo-ku, Chiba, Chiba, 260-8677, Japan.
Department of Advanced Cardiorhythm Therapeutics, Chiba University Graduate School of Medicine, Chiba, Japan.
Heart Vessels. 2021 Mar;36(3):321-329. doi: 10.1007/s00380-020-01705-x. Epub 2020 Sep 29.
Vasospastic angina (VSA) reportedly accounts for one form of sudden cardiac arrest (SCA). Intracoronary acetylcholine (ACh) testing is useful for diagnosing VSA although invasive provocation testing after SCA is a clinical challenge. In addition, even if the ACh test is positive, any causal relationship between VSA and SCA is often unclear because patients with VSA may have other underlying cardiac disorders.
A total of 20 patients without overt structural heart disease who had been fully resuscitated from SCA were included. All patients underwent the ACh provocation test and scrutiny such as cardiac computed tomography or magnetic resonance imaging. Patients were followed up for all-cause death or recurrent SCA including appropriate implantable cardioverter defibrillator therapy.
An ACh provocation test was performed 20 ± 17 days after cardiac arrest. Fifteen out of 20 (75.0%) patients had a positive ACh test and 2 (10.0%) had adverse events such as ventricular tachycardia and transient cardiogenic shock during the test. In patients with a positive ACh test, 6 of 15 (40.0%) patients had other overlapping cardiac disorders such as long QT syndrome, Brugada syndrome, cardiac sarcoidosis, myocarditis, or cardiomyopathy. Long-term prognosis was not different regardless of a positive ACh test or the presence of other cardiac disorders overlapping with VSA.
Three-quarters of the patients who had been resuscitated from SCA had a positive ACh test. Further examinations revealed other overlapping cardiac disorders in addition to VSA in 40% of patients with a positive ACh test.
据报道,血管痉挛性心绞痛(VSA)占心搏骤停(SCA)的一种形式。尽管 SCA 后侵入性激发试验是一项临床挑战,但冠状动脉内乙酰胆碱(ACh)测试对于诊断 VSA 很有用。此外,即使 ACh 测试呈阳性,VSA 和 SCA 之间的任何因果关系通常也不清楚,因为患有 VSA 的患者可能还有其他潜在的心脏疾病。
共纳入 20 名无明显结构性心脏病且已从 SCA 中完全复苏的患者。所有患者均接受 ACh 激发试验和心脏计算机断层扫描或磁共振成像等检查。对患者进行随访,以观察全因死亡或复发性 SCA,包括适当的植入式心脏复律除颤器治疗。
在心脏骤停后 20 ± 17 天进行了 ACh 激发试验。20 名患者中有 15 名(75.0%)ACh 激发试验阳性,2 名(10.0%)患者在试验过程中出现室性心动过速和短暂心源性休克等不良事件。在 ACh 激发试验阳性的患者中,15 名中有 6 名(40.0%)患者还有其他重叠性心脏疾病,如长 QT 综合征、Brugada 综合征、心脏结节病、心肌炎或心肌病。无论 ACh 试验阳性还是存在与 VSA 重叠的其他心脏疾病,长期预后均无差异。
从 SCA 中复苏的患者中有四分之三的 ACh 激发试验阳性。进一步检查发现,在 ACh 激发试验阳性的患者中,除 VSA 外,还有 40%的患者还有其他重叠性心脏疾病。